Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + lobaplatin vs paclitaxel + cisplatin in neoadjuvant and concurrent chemoradiotherapy for cervical cancer
ChiCTR-IIR-17011559Phase 3Recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Jul 2017
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Cervical Cancer (CC) comparing Paclitaxel + lobaplatin with Paclitaxel + cisplatin (2 arms). Primary endpoint: Change in cervical cancer mass. Started Jul 2017; status: recruiting.
02
Drugs
paclitaxellobaplatincisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR-IIR-17011559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17011559.